Skip to content

Clinical trials

Phase 1/2 Neurodegenerative Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Phase: Phase 1/2 Country / region: United States Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20171
20201
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Active, not recruiting1
Completed1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amylyx Pharmaceuticals Inc.1
Calico Life Sciences LLC1
Helixmith Co., Ltd.1
Thomas Advanced Medical LLC1
Titan Pharmaceuticals1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases6
Nervous System Diseases4
Neuromuscular Diseases3
Amyotrophic Lateral Sclerosis2
Brain Diseases2
Central Nervous System Diseases2
Musculoskeletal Diseases2
Alzheimer Disease1
Autoimmune Diseases1
COVID-191

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.